Facilitated By

San Antonio Medical Foundation

Trending Research

Top viewed research performed by San Antonio Bioscience Organizations


Basic Research

The University of Texas at San Antonio
Lee, Hyoung-gon

Southwest Research Institute (SwRI) and The University of Texas at San Antonio (UTSA) are working to synthesize novel highly potent derivatives of the antimalarial drug artemisinin with the goal of creating a powerful, cost-effective malaria treatment. Led by Dr. Shawn Blumberg of SwRI’s Chemistry and Chemical Engineering Division and Dr. Doug Frantz of the Department of Chemistry within UTSA’s College of Sciences, the work is supported by a $125,000 grant from the Connecting through Research Partnerships (CONNECT) program.

Southwest Research Institute
Dr. Shawn Blumberg